Medicare coverage of Novo Nordisk's Wegovy could cost up to $145B annually
https://seekingalpha.com/news/4144361-medicare-coverage-novo-nordisk-wegovy-could-cost-145b-annually?source=feed_sector_healthcare
Aug 27, 2024 - Use of Novo Nordisk's weight loss drug Wegovy for Medicare enrollees with obesity individuals and cardiovascular disease could cost up to $145B annually. Read more here.
0
GMS Gears Up to Report Q1 Earnings: Factors to Consider
https://www.zacks.com/stock/news/2327912/gms-gears-up-to-report-q1-earnings-factors-to-consider?cid=CS-ZC-FT-analyst_blog|earnings_preview-2327912
Aug 27, 2024 - Declining multi-family and commercial demand patterns are likely to be reflected in GMS' fiscal Q1 results.
0
Great Lakes Secures Multiple Dredging Contracts for $256M, Stock Up
https://www.zacks.com/stock/news/2327906/great-lakes-secures-multiple-dredging-contracts-for-256m-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2327906
Aug 27, 2024 - Strong bidding ability and project execution position GLDD well for the remainder of 2024 and beyond.
0
Stratasys Gears Up to Report Q2 Earnings: Key Factors to Note
https://www.zacks.com/stock/news/2327846/stratasys-gears-up-to-report-q2-earnings-key-factors-to-note?cid=CS-ZC-FT-analyst_blog|earnings_preview-2327846
Aug 27, 2024 - Forex headwinds and divestment of certain businesses are likely to have hurt SSYS' Q2 top line despite product updates and launches.
0
CuriosityStream Inc. (CURI) Is Up 5.36% in One Week: What You Should Know
https://www.zacks.com/stock/news/2327838/curiositystream-inc-curi-is-up-5-36-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2327838
Aug 27, 2024 - Does CuriosityStream Inc. (CURI) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Sezzle Inc. (SEZL) Is Up 3.32% in One Week: What You Should Know
https://www.zacks.com/stock/news/2327840/sezzle-inc-sezl-is-up-3-32-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2327840
Aug 27, 2024 - Does Sezzle Inc. (SEZL) have what it takes to be a top stock pick for momentum investors? Let's find out.
0
Ocugen to Begin Phase III Study on Eye Drug in Canada, Stock Up
https://www.zacks.com/stock/news/2327799/ocugen-to-begin-phase-iii-study-on-eye-drug-in-canada-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2327799
Aug 27, 2024 - OCGN receives Health Canada's No Objection Letter to begin a phase III study on OCU400 for treating retinitis pigmentosa. Shares rise.
0
BOX Gears Up to Report Q2 Earnings: Here's What to Expect
https://www.zacks.com/stock/news/2327862/box-gears-up-to-report-q2-earnings-here-s-what-to-expect?cid=CS-ZC-FT-analyst_blog|earnings_preview-2327862
Aug 27, 2024 - Box's Q2 performance will likely reflect strength across the Content Cloud platform and Box AI.
0
3 Large-Cap Growth Funds to Buy as Fed Gears Up for Rate Cuts
https://www.zacks.com/stock/news/2327765/3-large-cap-growth-funds-to-buy-as-fed-gears-up-for-rate-cuts?cid=CS-ZC-FT-mutual_fund_commentary-2327765
Aug 27, 2024 - Large-cap growth funds like FCNTX, JRAAX and TRLGX are likely to benefit from the Fed's rate cuts.
0
Ulta Beauty Gears Up for Q2 Earnings: Things to Keep in Mind
https://www.zacks.com/stock/news/2327803/ulta-beauty-gears-up-for-q2-earnings-things-to-keep-in-mind?cid=CS-ZC-FT-analyst_blog|earnings_preview-2327803
Aug 27, 2024 - ULTA's second-quarter performance is likely to reflect gains from strategic priorities. While elevated SG&A costs and a lower gross margin are expected.
0